
MedicQuant
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- medicquant.com
About
MedicQuant is a spin-out from the Gothelf Lab at iNANO, Aarhus University, Denmark, built on more than 11 years of research. Its patent-pending platform uses DNA nanotechnology to measure small-molecule drug concentrations in whole blood at the point of care, with laboratory-comparable accuracy in about 10 minutes. Assays are being developed first for anticoagulants so clinicians can make faster decisions in acute stroke care, and the same platform has shown proof of concept for antibiotics, anticancer drugs, and antirheumatic drugs. A disposable flow-front immunoassay cartridge processes whole blood with minimal handling and has been rated easy or very easy to use in usability studies.
Summary
MedicQuant is a Biotech company, founded in 2019.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/medicquant"><img src="https://indexed.vc/api/badge/company/medicquant" alt="MedicQuant on Indexed.vc" width="260" height="76" /></a>